SG
MEDS

StoneX Group’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

StoneX Group’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-433
Closed -$8.65K – 1286
2025
Q4 		$8.65K Buy
+433
New +$12.7K ﹤0.01% 1011

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

StoneX Group's MEDS Position: Q1 2026 in Review

StoneX Group sold out of DataMeds AI, Inc. Common Stock (MEDS) in Q1 2026, closing a stake of 433 shares — an estimated $8.65K sold.

StoneX Group first reported a position in MEDS in Q4 2025 and held it in 1 quarter. The position peaked at $8.65K in Q4 2025. 13 funds tracked by Wall St. Rank hold MEDS as of Q1 2026.

  • StoneX Group reported no remaining DataMeds AI, Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • StoneX Group sold 433 DataMeds AI, Inc. Common Stock shares in Q1 2026, an estimated $8.65K.
  • StoneX Group first reported a position in DataMeds AI, Inc. Common Stock in Q4 2025 and held it in 1 quarter.
  • StoneX Group's DataMeds AI, Inc. Common Stock position peaked at $8.65K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.